Reliability and validity of the M.D. Anderson symptom inventory (MDASI-BT) in the primary brain tumor patient population.

被引：0
|
作者：
Armstrong, T
Mendoza, T
Cohen, M
Morrissey, M
Cleeland, C
Gilbert, M
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
[2] UT, Houston Sch Nursing, Houston, TX USA
来源：
ONCOLOGY NURSING FORUM | 2005年 / 32卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
194
引用
收藏
页码：476 / 477
页数：2
相关论文
共 37 条
  • [11] EVALUATING PATIENT SYMPTOM BURDEN USING THE MD ANDERSON SYMPTOM INVENTORY-BRAIN TUMOR (MDASI-BT) IN EARLY PHASE TRIAL OF A MULTI-KINASE INHIBITOR
    Lindsley, Matthew
    Vera, Elizabeth
    Mendoza, Tito
    Wu, Jing
    Armstrong, Terri
    ONCOLOGY NURSING FORUM, 2021, 48 (02) : 31 - 32
  • [12] Identifying symptom recurrences in primary brain tumor patients using the MDASI-BT and qualitative interviews
    Alvina A. Acquaye
    Samuel S. Payén
    Elizabeth Vera
    Loretta A. Williams
    Mark R. Gilbert
    Shiao-Pei Weathers
    Terri S. Armstrong
    Journal of Patient-Reported Outcomes, 3
  • [13] Identifying symptom recurrences in primary brain tumor patients using the MDASI-BT and qualitative interviews
    Acquaye, Alvina A.
    Payen, Samuel S.
    Vera, Elizabeth
    Williams, Loretta A.
    Gilbert, Mark R.
    Weathers, Shiao-Pei
    Armstrong, Terri S.
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2019, 3 (01)
  • [14] The reliability and validity of the M. D. Anderson Symptom Inventory (MDASI-HN) as a measure of symptom burden in the head and neck cancer (HNC) patient population
    Rosenthal, DI
    Chambers, MS
    Mendoza, TR
    Asper, JA
    Kies, MS
    Weber, RS
    Garden, AS
    Ang, KK
    Wang, XS
    Cleeland, CS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 753S - 753S
  • [15] Validity and reliability of a French version of M.D. Anderson Dysphagia Inventory
    Jérôme R. Lechien
    Gaëtan Cavelier
    Marie-Paule Thill
    Laura Bousard
    Serge Blecic
    Jan Vanderwegen
    Sven Saussez
    Alexandra Rodriguez
    Didier Dequanter
    European Archives of Oto-Rhino-Laryngology, 2020, 277 : 3111 - 3119
  • [16] Content validity of self-report measurement instruments: An illustration from the development of the brain tumor module of the M.D. Anderson Symptom Inventory
    Armstrong, TS
    Cohen, MZ
    Eriksen, L
    Cleeland, C
    ONCOLOGY NURSING FORUM, 2005, 32 (03) : 669 - 676
  • [17] VALIDATION OF THE M. D. ANDERSON SYMPTOM INVENTORY SPINE TUMOR MODULE (MDASI-SP)
    Armstrong, Terri
    Gning, Ibrahima
    Mendoza, Tito
    Vera, Elizabeth
    Gilbert, Mark
    Rhines, Laurence
    Weinberg, Jeffrey
    Sanchez-Williams, Gisella
    Levin, Victor
    Burton, Allen
    Grossman, Tracy
    Cleeland, Charles
    NEURO-ONCOLOGY, 2008, 10 (05) : 876 - 876
  • [18] Reliability and validity of the M. D. Anderson Symptom Inventory Spine Tumor Module Clinical article
    Armstrong, Terri S.
    Gning, Ibrahima
    Mendoza, Tito R.
    Vera-Bolanos, Elizabeth
    Gilbert, Mark R.
    Rhines, Laurence D.
    Weinberg, Jeffrey S.
    Sanchez-Williams, Gisela
    Levin, Victor
    Burton, Allen W.
    Cleeland, Charles
    JOURNAL OF NEUROSURGERY-SPINE, 2010, 12 (04) : 421 - 430
  • [19] Psychometric validity and reliability of the Danish version of the MD Anderson Symptom Inventory Brain Tumor Module
    Piil, Karin
    Whisenant, Meagan
    Mendoza, Tito
    Armstrong, Terri
    Cleeland, Charles
    Nordentoft, Sara
    Williams, Loretta A.
    Jarden, Mary
    NEURO-ONCOLOGY PRACTICE, 2021, 8 (02) : 137 - 147
  • [20] Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer
    Sailors, Mary H.
    Bodurka, Diane C.
    Gning, Ibrahima
    Ramondetta, Lois M.
    Williams, Loretta A.
    Mendoza, Tito R.
    Agarwal, Sonika
    Sun, Charlotte C.
    Cleeland, Charles S.
    GYNECOLOGIC ONCOLOGY, 2013, 130 (02) : 323 - 328
1234